Cases 31 - 40 of 6,525
THERAVANCE BIOPHARMA R&D IP, LLC et al v. EUGIA PHARMA SPECIALITIES LTD. et al
as 1:2023cv06667
Plaintiff:
THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC., THERAVANCE BIOPHARMA IRELAND LIMITED and others
Defendant:
EUGIA PHARMA SPECIALITIES LTD., EUGIA US LLC, AUROBINDO PHARMA USA, INC. and others
Counter Claimant:
LUPIN INC.
Cause Of Action: 15 U.S.C. § 1126 Patent Infringement
SHANNON et al v. AUROBINDO PHARMA, LTD. et al
as 1:2023cv04229
Plaintiff:
STANLEY SHANNON and NELLIE F. LAWLER-SHANNON
Defendant:
AUROBINDO PHARMA, LTD., MYLAN LABORATORIES, LTD., MYLAN N.V. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
HAUGHTON v. AUROBINDO PHARMA, LTD. et al
as 1:2023cv03646
Plaintiff:
OCIE MAE HAUGHTON
Defendant:
AUROBINDO PHARMA, LTD., ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD, ARROW PHARM (MALTA) LTD. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
FANNING v. AUROBINDO PHARMA, LTD. et al
as 1:2023cv03540
Plaintiff:
LINDA FANNING
Defendant:
AUROBINDO PHARMA, LTD., ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD, AUROLIFE PHARMA, LLC and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
FWK HOLDINGS, LLC. v. GLAXOSMITHKLINE LLC et al
as 2:2023cv02958
Defendant:
GLAXOSMITHKLINE LLC formerly known as SMITHKLINE BEECHAM CORPORATION doing business as GLAXOSMITHKLINE, SMITHKLINE BEECHAM CORPORATION, TEVA PHARMACEUTICAL INDUSTRIES LTD and others
Plaintiff:
FWK Holdings LLC
Cause Of Action: 15 U.S.C. § 1 Antitrust Litigation
MLI RX LLC et al v. GLAXOSMITHKLINE LLC et al
as 2:2023cv02960
Defendant:
GLAXOSMITHKLINE LLC formerly known as SMITHKLINE BEECHAM CORPORATION doing business as GLAXOSMITHKLINE, SMITHKLINE BEECHAM CORPORATION, TEVA PHARMACEUTICAL INDUSTRIES LTD and others
Plaintiff:
MLI RX LLC, AMERISOURCEBERGEN CORP., AMERISOURCEBERGEN DRUG CORP. and others
Interested Party:
GlaxoSmithKline LLC
Cause Of Action: 15 U.S.C. § 1 Antitrust Litigation
MORRIS & DICKSON CO., L.L.C. v. GLAXOSMITHKLINE LLC et al
as 2:2023cv02956
Defendant:
GLAXOSMITHKLINE LLC formerly known as SMITHKLINE BEECHAM CORPORATION doing business as GLAXOSMITHKLINE, SMITHKLINE BEECHAM CORPORATION, TEVA PHARMACEUTICAL INDUSTRIES LTD and others
Plaintiff:
MORRIS & DICKSON CO., L.L.C.
Cause Of Action: 15 U.S.C. § 1 Antitrust Litigation
BUXTON v. AUROBINDO PHARMA, LTD. et al
as 1:2023cv02933
Plaintiff:
DIXIE B BUXTON
Defendant:
AUROBINDO PHARMA, LTD., MYLAN LABORATORIES LTD., MYLAN N.V. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Utah-Idaho Teamsters Security Fund v. Teva Pharmaceutical Industries Ltd. et al
as 1:2023cv11198
Plaintiff:
Utah-Idaho Teamsters Security Fund
Defendant:
Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Teva Branded Pharmaceutical Products R&D, Inc. and others
Cause Of Action: 15 U.S.C. § 2 Antitrust Litigation
MERRILL v. AUROBINDO PHARMA, LTD. et al
as 1:2023cv02857
Plaintiff:
DOUGLAS MERRILL
Defendant:
AUROBINDO PHARMA, LTD., HETERO DRUGS, LTD., HETERO LABS, LTD. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
